Category In The News
The panel focused on new funding models for disease research foundations, including for-profit direct investment in early stage biotech/medtech companies.
The 17 member advisory panel will help PBTF evaluate research funding priorities and guide investments.
Drs. Linda Liau and Albert Lai discussed the future of brain cancer research with ABC2 CEO Max Wallace and brain tumor community guests.
Our beloved ABC2 teammate Mark Green was recently interviewed by our good friend Alex Case about living with brain cancer.
Join us for the screening and meet Maria Parker, the inspiring cyclist profiled in the film. Proceeds benefit 3000 Miles To A Cure in partnership with ABC2.
Progress continues on the UF pediatric immunotherapy trial funded by ABC2, FBTA and Paul Hale of the Bret Hale Memorial Fund.
ABC2 funded the research of Hai Yan, M.D., Ph.D., at Duke University School of Medicine.
This ABC2-funded research by Dr. Greg Riggins at Johns Hopkins University is featured in The Baltimore Sun.
We've funded early research at Duke that's now being developed by Celldex - a leading company featured in the Seeking Alpha article.